BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1614059)

  • 1. Acute renal effects of felodipine in hypertensive patients with kidney disease.
    Huysmans FT; van Hamersvelt HW; Sluiter HE; Wetzels JF; Koene RA
    Kidney Int Suppl; 1992 May; 36():S106-9. PubMed ID: 1614059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natriuretic effect of the dihydropyridine calcium antagonist felodipine: a placebo-controlled study involving intravenous angiotensin II in normotensive volunteers.
    Sluiter HE; Wetzels JF; Huysmans FT; Koene RA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S154-61. PubMed ID: 2455121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of felodipine on renal haemodynamics and tubular sodium handling in cyclosporin-treated renal transplant recipients.
    Sørensen SS; Skovbon H; Eiskjaer H; Thomsen K; Pedersen EB
    Nephrol Dial Transplant; 1992; 7(1):69-78. PubMed ID: 1316584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of felodipine in patients with reduced renal function.
    Herlitz H
    Kidney Int Suppl; 1992 May; 36():S110-3. PubMed ID: 1614060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of felodipine: a review of experimental evidence and clinical data.
    DiBona GF
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S29-32. PubMed ID: 1693722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between cyclosporine and felodipine in renal transplant recipients.
    Pedersen EB; Sørensen SS; Eiskjaer H; Skovbon H; Thomsen K
    Kidney Int Suppl; 1992 May; 36():S82-6. PubMed ID: 1614074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of felodipine--a review.
    Elmfeldt D; Nordlander M; Edgar B
    Kidney Int Suppl; 1992 May; 36():S54-60. PubMed ID: 1614069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and antihypertensive effects of felodipine in hypertensive patients.
    Leonetti G; Gradnik R; Terzoli L; Fruscio M; Rupoli L; Cuspidi C; Sampieri L; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S161-3. PubMed ID: 2856695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
    Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubular site of action of felodipine.
    Dibona GF; Sawin LL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):420-4. PubMed ID: 6694119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
    Nielsen CB; Pedersen EB
    Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nisoldipine on renal function in normal volunteers and essential hypertensive patients.
    Ruilope LM; Miranda B; Garcia-Robles R; Bigorra J; Oliet A; Alcazar JM; Sancho Rof J; Rodicio JL
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):90-3. PubMed ID: 2468941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
    Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.